SCHEMBL21156590

SCHEMBL21156590

Cc1c(C(=O)OC(C)C)cc2c(-c3ccccc3)ccn2c1C(C)N1CCOCC1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EED O75530 10/20 0.47
RBBP4 Q09028 10/20 0.47
SUZ12 Q15022 10/20 0.47
EZH2 Q15910 10/20 0.47
AEBP2 Q6ZN18 10/20 0.47
KDM4E B2RXH2 2/20 0.37
EPHX1 P07099 1/20 0.37
PPARG P37231 1/20 0.37
ALDH1A1 P00352 3/20 0.35
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35
CYP2C19 P33261 1/20 0.35
DGAT1 O75907 2/20 0.35
SOAT1 P35610 2/20 0.35
HPGD P15428 2/20 0.35
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21157377 0.91 EED (0.46) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL21113378 0.91 EED (0.47) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL19964861 0.90 EED (0.49) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL19964418 0.89 EED (0.47) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL21157366 0.89 EED (0.46) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL19964531 0.89 EED (0.48) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL19964847 0.89 EED (0.45) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL21113297 0.89 EED (0.46) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL21156583 0.89 EZH2 (0.44) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL28886499 0.88 EED (0.43) EEDRBBP4SUZ12EZH2AEBP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109790160-B Pyrido five-membered aromatic ring compound, preparation method and application thereof 上海海和药物研究开发股份有限公司 2022-11-15 CN disclosed
US-10968215-B2 Pyrido five-element aromatic ring compound, preparation method therefor and use thereof SHANGHAI HAIHE PHARMACEUTICAL CO., LTD. (CN) 2021-04-06 US disclosed
EP-3524602-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Haihe Pharmaceutical Co., Ltd. (CN) 2019-08-14 EP disclosed
US-20190211010-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF HAIHE BIOPHARMA CO. LTD. (CN) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10968215-B2 Pyrido five-element aromatic ring compound, preparation method therefor and use thereof EZH2, IKZF2, SUZ12 EED 41/4885RBBP4 288/4885SUZ12 3/4885
US-20190211010-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF EZH2, IKZF2, SUZ12 EED 41/4885RBBP4 288/4885SUZ12 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.